Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Kahn

Showing results (11-20 of 346) with videos related to

Pageof 35
Sort By:
Diabetes Care|June 29, 2011
What's next for diabetes prevention?Steven E Kahn, Kristina M Utzschneider
The Journal of Clinical Endocrinology and Metabolism|September 4, 2008
Glucose control, macro- and microvascular disease, and the Food and Drug Administration: let's keep our eye on the ballSteven E Kahn, William T Cefalu
Diabetologia|March 17, 2015
Medications for type 2 diabetes: how will we be treating patients in 50 years?Steven E Kahn, John B Buse
Diabetes|December 20, 2024
The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes ResearchDavid A D'Alessio, Steven E Kahn
Diabetes Care|December 20, 2024
The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes ResearchDavid A D'Alessio, Steven E Kahn
Journal of the American Society of Nephrology : JASN|August 20, 2016
SGLT2 Inhibitors-Sweet Success for Diabetic Kidney Disease?Ian H de Boer, Steven E Kahn
Diabetes Care|June 24, 2024
The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal FeatureDavid A D'Alessio, Steven E Kahn, Hindrik Mulder
Diabetologia|June 23, 2024
The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal featureDavid A D'Alessio, Steven E Kahn, Hindrik Mulder
Diabetologia|September 7, 2020
Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemiaNathalie Esser, Kristina M Utzschneider, Steven E Kahn
Diabetes|June 24, 2024
The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal FeatureDavid A D'Alessio, Steven E Kahn, Hindrik Mulder
Pageof 35

Showing results (11-20 of 346) with videos related to

Sort By:
Pageof 35
Diabetes Care|June 29, 2011
What's next for diabetes prevention?Steven E Kahn, Kristina M Utzschneider
The Journal of Clinical Endocrinology and Metabolism|September 4, 2008
Glucose control, macro- and microvascular disease, and the Food and Drug Administration: let's keep our eye on the ballSteven E Kahn, William T Cefalu
Diabetologia|March 17, 2015
Medications for type 2 diabetes: how will we be treating patients in 50 years?Steven E Kahn, John B Buse
Diabetes|December 20, 2024
The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes ResearchDavid A D'Alessio, Steven E Kahn
Diabetes Care|December 20, 2024
The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes ResearchDavid A D'Alessio, Steven E Kahn
Journal of the American Society of Nephrology : JASN|August 20, 2016
SGLT2 Inhibitors-Sweet Success for Diabetic Kidney Disease?Ian H de Boer, Steven E Kahn
Diabetes Care|June 24, 2024
The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal FeatureDavid A D'Alessio, Steven E Kahn, Hindrik Mulder
Diabetologia|June 23, 2024
The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal featureDavid A D'Alessio, Steven E Kahn, Hindrik Mulder
Diabetologia|September 7, 2020
Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemiaNathalie Esser, Kristina M Utzschneider, Steven E Kahn
Diabetes|June 24, 2024
The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal FeatureDavid A D'Alessio, Steven E Kahn, Hindrik Mulder
Pageof 35